Mifamurtide sodium
Product Specifications
CAS Number
90825-43-7
Target
NOD-like Receptor (NLR)
Related Pathways
Immunology/Inflammation
Bioactivity
Mifamurtide sodium is a drug against osteosarcoma, a kind of bone cancer mainly affecting children and young adults. It was approved in Europe in March 2009.
Smiles
[Na].CCCCCCCCCCCCCCCC(=O)OC[C@H](COP(O)(=O)OCCNC(=O)[C@H](C)NC(=O)CC[C@@H](NC(=O)[C@H](C)NC(=O)[C@@H](C)O[C@@H]([C@H](O)[C@H](O)CO)[C@@H](NC(C)=O)C=O)C(N)=O)OC(=O)CCCCCCCCCCCCCCC
Molecular Formula
C59H108N6NaO19P
Molecular Weight
1259.48
Shipping Conditions
Cool pack
Storage Temperature
-20°C
Available Sizes
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
MBS6194088-01 0.1 mL
BRMS1 (Breast Cancer Metastasis Suppressor 1, Breast Cancer Metastasis-suppressor 1, DKFZp564A063) (MaxLight 405)
Ask
View Details 
MBS6194088-02 5x 0.1 mL
BRMS1 (Breast Cancer Metastasis Suppressor 1, Breast Cancer Metastasis-suppressor 1, DKFZp564A063) (MaxLight 405)
Ask
View Details 
GTR15082820 1 Vial
Lentiviral human PEX3 shRNA (UAS) - Lentiviral human PEX3 shRNA (UAS, GFP) (25)
Ask
View Details